Clarified Precision Medicine
Lincoln Nadauld is a prominent figure in the field of precision medicine, currently serving as the Chief Executive Officer at Culmination Bio since April 2022. In addition to this role, Lincoln Nadauld holds a position as a Clinical Assistant Professor (Affiliated) at Stanford University School of Medicine and co-founded both Clarified Precision Medicine and Guidance Genomics. Previously, Lincoln Nadauld was the Vice President and Chief of Precision Health & Academics at Intermountain Healthcare, where leadership encompassed precision health across multiple hospitals and clinics, along with overseeing Graduate Medical Education and enterprise-wide research functions. Educational credentials include a fellowship in Medical Oncology from Stanford University, an MD and PhD from the University of Utah, and a Bachelor's degree from Brigham Young University.
This person is not in the org chart
This person is not in any teams
Clarified Precision Medicine
Clarified Precision Medicine is the first scalable molecular tumor board with a combination of AI-based platform plus medical group, offering expert clinical somatic and pharmacogenomics consultations through its ClarifiedSelect™ and OncoGuardian™ solutions. Clarified accelerates the delivery of guidelines-based genomic insights to patients and providers by bringing together nationally recognized experts in medical oncology, oncology pharmacy, data integration, and molecular pathology who have over 100 years of collective experience in the application of precision oncology. For more information, visit: www.clarifiedprecisionmedicine.com